AMPK Methods and Protocols

(Rick Simeone) #1

  1. Lek M, Karczewski KJ, Minikel EV, Samocha
    KE, Banks E, Fennell T, O’Donnell-Luria AH,
    Ware JS, Hill AJ, Cummings BB, Tukiainen T,
    Birnbaum DP, Kosmicki JA, Duncan LE,
    Estrada K, Zhao F, Zou J, Pierce-Hoffman E,
    Berghout J, Cooper DN, Deflaux N,
    DePristo M, Do R, Flannick J, Fromer M,
    Gauthier L, Goldstein J, Gupta N,
    Howrigan D, Kiezun A, Kurki MI, Moonshine
    AL, Natarajan P, Orozco L, Peloso GM,
    Poplin R, Rivas MA, Ruano-Rubio V, Rose
    SA, Ruderfer DM, Shakir K, Stenson PD,
    Stevens C, Thomas BP, Tiao G, Tusie-Luna
    MT, Weisburd B, Won HH, Yu D, Altshuler
    DM, Ardissino D, Boehnke M, Danesh J,
    Donnelly S, Elosua R, Florez JC, Gabriel SB,
    Getz G, Glatt SJ, Hultman CM, Kathiresan S,
    Laakso M, McCarroll S, McCarthy MI,
    McGovern D, McPherson R, Neale BM,
    Palotie A, Purcell SM, Saleheen D, Scharf JM,
    Sklar P, Sullivan PF, Tuomilehto J, Tsuang MT,
    Watkins HC, Wilson JG, Daly MJ, MacArthur
    DG (2016) Analysis of protein-coding genetic
    variation in 60,706 humans. Nature 536
    (7616):285–291. https://doi.org/10.1038/
    nature19057

  2. Walsh R, Thomson KL, Ware JS, Funke BH,
    Woodley J, McGuire KJ, Mazzarotto F, Blair E,
    Seller A, Taylor JC, Minikel EV, Exome
    Aggregation C, MacArthur DG, Farrall M,
    Cook SA, Watkins H (2017) Reassessment of
    Mendelian gene pathogenicity using 7,855 car-
    diomyopathy cases and 60,706 reference sam-
    ples. Genet Med 19(2):192–203.https://doi.
    org/10.1038/gim.2016.90

  3. Murphy RT, Mogensen J, McGarry K, Bahl A,
    Evans A, Osman E, Syrris P, Gorman G,
    Farrell M, Holton JL, Hanna MG, Hughes S,
    Elliott PM, Macrae CA, McKenna WJ (2005)
    Adenosine monophosphate-activated protein
    kinase disease mimicks hypertrophic cardiomy-
    opathy and Wolff-Parkinson-White syndrome:
    natural history. J Am Coll Cardiol 45
    (6):922–930. https://doi.org/10.1016/j.
    jacc.2004.11.053. S0735-1097(04)02500-
    8 [pii]

  4. Akman HO, Sampayo JN, Ross FA, Scott JW,
    Wilson G, Benson L, Bruno C, Shanske S,
    Hardie DG, Dimauro S (2007) Fatal infantile
    cardiac glycogenosis with phosphorylase kinase
    deficiency and a mutation in the gamma2-
    subunit of AMP-activated protein kinase.
    Pediatr Res 62(4):499–504.https://doi.org/
    10.1203/PDR.0b013e3181462b86.
    00006450-200710000-00022 [pii]

  5. Burwinkel B, Scott JW, Buhrer C, van Land-
    eghem FK, Cox GF, Wilson CJ, Grahame
    Hardie D, Kilimann MW (2005) Fatal congen-
    ital heart glycogenosis caused by a recurrent


activating R531Q mutation in the gamma
2-subunit of AMP-activated protein kinase
(PRKAG2), not by phosphorylase kinase defi-
ciency. Am J Hum Genet 76(6):1034–1049.
https://doi.org/10.1086/430840. S0002-
9297(07)62898-5 [pii]


  1. Sternick EB, Oliva A, Magalhaes LP, Gerken
    LM, Hong K, Santana O, Brugada P,
    Brugada J, Brugada R (2006) Familial
    pseudo-Wolff-Parkinson-White syndrome. J
    Cardiovasc Electrophysiol 17(7):724–732.
    https://doi.org/10.1111/j.1540-8167.2006.
    00485.x. JCE485 [pii]

  2. Tan HL, van der Wal AC, Campian ME, Kruys-
    wijk HH, ten Hove Jansen B, van Doorn DJ,
    Oskam HJ, Becker AE, Wilde AA (2008)
    Nodoventricular accessory pathways in
    PRKAG2-dependent familial preexcitation
    syndrome reveal a disorder in cardiac develop-
    ment. Circ Arrhythm Electrophysiol 1
    (4):276–281. https://doi.org/10.1161/CIR
    CEP.108.782862. CIRCEP.108.782862 [pii]

  3. Zhang LP, Hui B, Gao BR (2011) High risk of
    sudden death associated with a PRKAG2-
    related familial Wolff-Parkinson-White syn-
    drome. J Electrocardiol 44(4):483–486.
    https://doi.org/10.1016/j.jelectrocard.2010.
    02.009

  4. Gollob MH, Seger JJ, Gollob TN, Tapscott T,
    Gonzales O, Bachinski L, Roberts R (2001)
    Novel PRKAG2 mutation responsible for the
    genetic syndrome of ventricular preexcitation
    and conduction system disease with childhood
    onset and absence of cardiac hypertrophy. Cir-
    culation 104(25):3030–3033

  5. Yang X, Mudgett J, Bou-About G, Champy
    MF, Jacobs H, Monassier L, Pavlovic G,
    Sorg T, Herault Y, Petit-Demouliere B, Lu K,
    Feng W, Wang H, Ma LJ, Askew R, Erion MD,
    Kelley DE, Myers RW, Li C, Guan HP (2016)
    Physiological expression of AMPKgamma2RG
    mutation causes Wolff-Parkinson-White syn-
    drome and induces kidney injury in mice. J
    Biol Chem 291:23428.https://doi.org/10.
    1074/jbc.M116.738591

  6. Arad M, Moskowitz IP, Patel VV, Ahmad F,
    Perez-Atayde AR, Sawyer DB, Walter M, Li
    GH, Burgon PG, Maguire CT, Stapleton D,
    Schmitt JP, Guo XX, Pizard A,
    Kupershmidt S, Roden DM, Berul CI, Seid-
    man CE, Seidman JG (2003) Transgenic mice
    overexpressing mutant PRKAG2 define the
    cause of Wolff-Parkinson-White syndrome in
    glycogen storage cardiomyopathy. Circulation
    107(22):2850–2856. https://doi.org/10.
    1161/01.CIR.0000075270.13497.2B. 01.
    CIR.0000075270.13497.2B [pii]


614 Arash Yavari et al.

Free download pdf